A Randomized Phase 2 Study of Anti-IL-8 Therapy Versus Standard of care in the Treatment of Hospitalized Cancer Patients with Severe COVID-19
Matthew Dallos, Assistant Professor of Medicine at CUMC, Division of Hematology/Oncology
Matthew Dallos, Assistant Professor of Medicine at CUMC, Division of Hematology/Oncology